Friedman M - Search Results

1

Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.

Baluom M, Friedman M, Assaf P, Haj-Yehia AI, Rubinstein A. Baluom M, et al. Among authors: friedman m. Pharm Res. 2000 Sep;17(9):1071-6. doi: 10.1023/a:1026449527891. Pharm Res. 2000. PMID: 11087038

2

Adsorption of fluorescein dyes on albumin microspheres.

Egbaria K, Friedman M. Egbaria K, et al. Among authors: friedman m. Pharm Res. 1992 May;9(5):629-35. doi: 10.1023/a:1015897909739. Pharm Res. 1992. PMID: 1608894 Free article.

3

Sustained-release delivery systems for treatment of dental diseases.

Friedman M, Steinberg D. Friedman M, et al. Pharm Res. 1990 Apr;7(4):313-7. doi: 10.1023/a:1015898717936. Pharm Res. 1990. PMID: 2194197 Review.

4

Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.

Hussein Z, Friedman M. Hussein Z, et al. Among authors: friedman m. Pharm Res. 1990 Nov;7(11):1167-71. doi: 10.1023/a:1015988410977. Pharm Res. 1990. PMID: 2293217

5

Computerized model for evaluating the kinetics of in vitro release of valpromide from controlled-release tablets under nonsink conditions.

Rubinstein A, Gonen A, Friedman M. Rubinstein A, et al. Among authors: friedman m. J Pharm Sci. 1986 Oct;75(10):959-61. doi: 10.1002/jps.2600751010. J Pharm Sci. 1986. PMID: 3098956

6

Rapid gas chromatographic assay for monitoring valproic acid and valpromide in plasma.

Bialer M, Friedman M, Rubinstein A. Bialer M, et al. Among authors: friedman m. J Pharm Sci. 1984 Jul;73(7):991-3. doi: 10.1002/jps.2600730734. J Pharm Sci. 1984. PMID: 6432998

7

Modeling of drug release from erodible tablets.

Katzhendler I, Hoffman A, Goldberger A, Friedman M. Katzhendler I, et al. Among authors: friedman m. J Pharm Sci. 1997 Jan;86(1):110-5. doi: 10.1021/js9600538. J Pharm Sci. 1997. PMID: 9002469

8

The effect of intestinal bacteria adherence on drug diffusion through solid films under stationary conditions.

Rubinstein A, Radai R, Friedman M, Fischer P, Rokem JS. Rubinstein A, et al. Among authors: friedman m. Pharm Res. 1997 Apr;14(4):503-7. doi: 10.1023/a:1012159818727. Pharm Res. 1997. PMID: 9144739

9

Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: pharmacodynamic rationale for sustained release preparation of the drug.

Hoffman A, Lomnicky Y, Luria MH, Gilhar D, Friedman M. Hoffman A, et al. Among authors: friedman m. Pharm Res. 1999 Jul;16(7):1093-7. doi: 10.1023/a:1018900219616. Pharm Res. 1999. PMID: 10450936

10

Correlation between drug release kinetics from proteineous matrix and matrix structure: EPR and NMR study.

Katzhendler I, Mäder K, Friedman M. Katzhendler I, et al. Among authors: friedman m. J Pharm Sci. 2000 Mar;89(3):365-81. doi: 10.1002/(SICI)1520-6017(200003)89:3<365::AID-JPS8>3.0.CO;2-D. J Pharm Sci. 2000. PMID: 10707017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,692 results

Search Page

Filters